This section highlights three key biomarkers, short-chain fatty acids (SCFAs), calprotectin, and zonulin, that represent potential mechanistic links between gut dysbiosis and cardiovascular disease in the context of IBD (Table 2). Here, HP is linked to cardiovascular disorder.